2014
DOI: 10.1016/j.clon.2013.09.003
|View full text |Cite|
|
Sign up to set email alerts
|

Association between Smoking and p53 Mutation in Lung Cancer: A Meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
24
1

Year Published

2014
2014
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 36 publications
(28 citation statements)
references
References 35 publications
3
24
1
Order By: Relevance
“…In addition, the TP53 mutation is associated with smoking-induced lung cancer. Smokers with lung cancer have a higher risk of TP53 mutation than non-smokers (22). However, our current data shed little light on the question of whether SWI/SNF mutations are associated with smokers in lung cancer.…”
Section: Discussioncontrasting
confidence: 42%
“…In addition, the TP53 mutation is associated with smoking-induced lung cancer. Smokers with lung cancer have a higher risk of TP53 mutation than non-smokers (22). However, our current data shed little light on the question of whether SWI/SNF mutations are associated with smokers in lung cancer.…”
Section: Discussioncontrasting
confidence: 42%
“…Genetically, carcinogenesis involves multiple processes by which the activation of oncogenes and the inactivation of tumor suppressor genes represent central factors for tumor development and progression of the disease [33]. Tumor suppressor mutations, as reported in LC cells, may contribute to the pathogenesis of invasive cancer [12]. p53 is widely known as a tumor suppressor, while wild-type p53 has been linked with apoptosis, cell cycle arrest, and DNA repair [34].…”
Section: Discussionmentioning
confidence: 99%
“…Recent evidence has revealed that the pattern and frequency of p53 mutations vary among cancer populations depending on the geographical origin. LC commonly presents with p53 gene mutations [12], with 81% of squamous cell carcinoma as well as 46% of lung adenocarcinoma patients carrying a p53 mutation. Likewise, reports have indicated there to exist a high mutation rate in hotspot regions [13].…”
Section: Introductionmentioning
confidence: 99%
“…Most somatic mutations are inactivating mutations (missense and nonsense mutations). The lack of difference in smoking habits (over 5 pack-years) among tumor subtypes (96% [50]) in laryngeal, 69% in oral cavity, 64% in oropharyngeal and 67% in hypopharyngeal HNSCC) fails to explain the difference in TP53 mutations.However, there is a significant difference in HPV infection among subsites (10% HPV+ rate in oral cavity, 62% in oropharyngeal, 7% in laryngeal and 50% in hypopharyngeal HNSCC, p = 4.10E − 12) [51]. TP53 mutations in HPV− tumors only across subsites showed no difference, suggesting that mutation profile depends more on HPV than tumor subtype, which is consistent with different oncogenetic processes.…”
Section: Mutational Profiles In Specific Clinical Conditionsmentioning
confidence: 80%